Shots: Elanco acquires Bayer’s animal health business in cash & stock transaction, making a total deal value $7.6B. Bayer to get $5.32B cash as up front and $2.28B/~68M as Elanco’s […]readmore
Tags : Acquire
Shots: Elanco acquires Bayer’s animal health business in cash & stock transaction, making a total deal value $7.6B. Bayer to get $5.32B cash as up front and $2.28B/~68M as Elanco’s […]readmore
Shots: Jazz acquires Cavion, in all stock transaction making total deal value $312.5M. Cavion to receive $52.5M up front, ~$260M milestones based on certain clinical, regulatory and commercial activities The […]readmore
Shots: Atricure acquires SentreHEART in all stock and cash transaction. Atricure to pay upfront as ~$40M in cash and AtriCure common stock, ~$140M milestones based on aMAZE IDE clinical trial […]readmore
Shots: BlueRock to get $240M in cash as upfront and $360M as development milestones. In 2016, Bayer and Versant Ventures formed a joint venture establishing BlueRock Therapeutics, Bayer currently holds […]readmore
Shots: Ligand will acquire Ab Initio for $12M in cash as Ab Initio’s antigen technology is complimenting Ligand’s OmniAb therapeutic antibody discovery platform which will further strengthen and expand ligand’s […]readmore
Shots: Genentech & Convelo collaborate to discover and develop remyelination therapies for patients with neurological disorders including multiple sclerosis Convelo to receive up front and research support from Genentech. Genentech […]readmore
Shots: Varian acquires the Boston Scientific drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products for the treatment of arteriovenous malformations and hypervascular tumors for $90M The focus of […]readmore
Shots: AbbVie to acquire Allergan in cash & stock transaction making the total deal value $63B, based on the closing price of AbbVie’s common stock of $78.45 on June 24, […]readmore
Shots: Pfizer to acquire Array Biopharma in all-stock transaction for $48/share making the total deal value ~11.4B, with its expected completion in H2’19 The focus of the acquisition is to […]readmore